|4Nov 14, 6:08 PM ET

SNYDER DAVID S 4

4 · Coya Therapeutics, Inc. · Filed Nov 14, 2024

Insider Transaction Report

Form 4
Period: 2024-11-14
SNYDER DAVID S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2024-11-14$7.19/sh+1,800$12,9348,800 total

Documents

1 file
  • 4
    ownership.xmlPrimary